Jennison Associates’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-31,334
Closed -$602K 689
2019
Q3
$602K Sell
31,334
-769,474
-96% -$14.8M ﹤0.01% 591
2019
Q2
$23.7M Sell
800,808
-544,191
-40% -$16.1M 0.02% 318
2019
Q1
$63.9M Buy
1,344,999
+161,538
+14% +$7.67M 0.06% 186
2018
Q4
$42.7M Sell
1,183,461
-202,750
-15% -$7.32M 0.05% 241
2018
Q3
$85.3M Buy
1,386,211
+76,390
+6% +$4.7M 0.08% 170
2018
Q2
$88.5M Sell
1,309,821
-191,774
-13% -$13M 0.09% 169
2018
Q1
$81.5M Buy
1,501,595
+108,222
+8% +$5.87M 0.08% 180
2017
Q4
$83.3M Sell
1,393,373
-486,240
-26% -$29.1M 0.08% 189
2017
Q3
$91.3M Sell
1,879,613
-5,462
-0.3% -$265K 0.09% 173
2017
Q2
$99.1M Sell
1,885,075
-1,249,841
-40% -$65.7M 0.11% 158
2017
Q1
$142M Sell
3,134,916
-293,944
-9% -$13.3M 0.15% 100
2016
Q4
$130M Sell
3,428,860
-135,385
-4% -$5.12M 0.14% 115
2016
Q3
$135M Sell
3,564,245
-147,450
-4% -$5.56M 0.15% 122
2016
Q2
$65.3M Buy
3,711,695
+21,505
+0.6% +$378K 0.07% 237
2016
Q1
$44.9M Buy
3,690,190
+38,180
+1% +$464K 0.05% 300
2015
Q4
$88.9M Sell
3,652,010
-112,009
-3% -$2.73M 0.09% 189
2015
Q3
$66.8M Buy
3,764,019
+669,110
+22% +$11.9M 0.07% 247
2015
Q2
$54.6M Buy
3,094,909
+113,708
+4% +$2.01M 0.05% 319
2015
Q1
$93.4M Buy
2,981,201
+611,618
+26% +$19.2M 0.09% 212
2014
Q4
$69.2M Buy
2,369,583
+2,137,858
+923% +$62.4M 0.06% 270
2014
Q3
$4.79M Buy
231,725
+338
+0.1% +$6.99K ﹤0.01% 502
2014
Q2
$5.73M Sell
231,387
-26,325
-10% -$652K 0.01% 493
2014
Q1
$5.46M Buy
257,712
+848
+0.3% +$18K 0.01% 505
2013
Q4
$4.61M Buy
+256,864
New +$4.61M ﹤0.01% 508